168 related articles for article (PubMed ID: 25017886)
21. The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.
Qiao F; Atkinson C; Kindy MS; Shunmugavel A; Morgan BP; Song H; Tomlinson S
Am J Pathol; 2010 Dec; 177(6):3061-70. PubMed ID: 20952585
[TBL] [Abstract][Full Text] [Related]
22. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.
Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR
Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995
[TBL] [Abstract][Full Text] [Related]
23. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms.
Norimatsu Y; Ohmori T; Kimura A; Madoiwa S; Mimuro J; Seichi A; Yatomi Y; Hoshino Y; Sakata Y
Am J Pathol; 2012 Apr; 180(4):1625-35. PubMed ID: 22417787
[TBL] [Abstract][Full Text] [Related]
24. Effect of VEGF and CX43 on the promotion of neurological recovery by hyperbaric oxygen treatment in spinal cord-injured rats.
Liu X; Zhou Y; Wang Z; Yang J; Gao C; Su Q
Spine J; 2014 Jan; 14(1):119-27. PubMed ID: 24183749
[TBL] [Abstract][Full Text] [Related]
25. Early graft of neural precursors in spinal cord compression reduces glial cyst and improves function.
Boido M; Garbossa D; Vercelli A
J Neurosurg Spine; 2011 Jul; 15(1):97-106. PubMed ID: 21456892
[TBL] [Abstract][Full Text] [Related]
26. Increased growth factor expression and cell proliferation after contusive spinal cord injury.
Zai LJ; Yoo S; Wrathall JR
Brain Res; 2005 Aug; 1052(2):147-55. PubMed ID: 16005441
[TBL] [Abstract][Full Text] [Related]
27. Methothrexate attenuates early neutrophil infiltration and the associated lipid peroxidation in the injured spinal cord but does not induce neurotoxicity in the uninjured spinal cord in rats.
Sanli AM; Serbes G; Sargon MF; Calişkan M; Kilinç K; Bulut H; Sekerci Z
Acta Neurochir (Wien); 2012 Jun; 154(6):1045-54. PubMed ID: 22354719
[TBL] [Abstract][Full Text] [Related]
28. The cellular inflammatory response in human spinal cords after injury.
Fleming JC; Norenberg MD; Ramsay DA; Dekaban GA; Marcillo AE; Saenz AD; Pasquale-Styles M; Dietrich WD; Weaver LC
Brain; 2006 Dec; 129(Pt 12):3249-69. PubMed ID: 17071951
[TBL] [Abstract][Full Text] [Related]
29. The role of thrombospondin-1 and transforming growth factor-beta after spinal cord injury in the rat.
Wang X; Chen W; Liu W; Wu J; Shao Y; Zhang X
J Clin Neurosci; 2009 Jun; 16(6):818-21. PubMed ID: 19342245
[TBL] [Abstract][Full Text] [Related]
30. Genetically modified mesenchymal stem cells (MSCs) promote axonal regeneration and prevent hypersensitivity after spinal cord injury.
Kumagai G; Tsoulfas P; Toh S; McNiece I; Bramlett HM; Dietrich WD
Exp Neurol; 2013 Oct; 248():369-80. PubMed ID: 23856436
[TBL] [Abstract][Full Text] [Related]
31. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury.
Okada S; Nakamura M; Mikami Y; Shimazaki T; Mihara M; Ohsugi Y; Iwamoto Y; Yoshizaki K; Kishimoto T; Toyama Y; Okano H
J Neurosci Res; 2004 Apr; 76(2):265-76. PubMed ID: 15048924
[TBL] [Abstract][Full Text] [Related]
32. Spinal cord injury: emerging beneficial role of reactive astrocytes' migration.
Renault-Mihara F; Okada S; Shibata S; Nakamura M; Toyama Y; Okano H
Int J Biochem Cell Biol; 2008; 40(9):1649-53. PubMed ID: 18434236
[TBL] [Abstract][Full Text] [Related]
33. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
34. Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord.
Sharma HS; Ali SF; Dong W; Tian ZR; Patnaik R; Patnaik S; Sharma A; Boman A; Lek P; Seifert E; Lundstedt T
Ann N Y Acad Sci; 2007 Dec; 1122():197-218. PubMed ID: 18077574
[TBL] [Abstract][Full Text] [Related]
35. The effect of long-term release of Shh from implanted biodegradable microspheres on recovery from spinal cord injury in mice.
Lowry N; Goderie SK; Lederman P; Charniga C; Gooch MR; Gracey KD; Banerjee A; Punyani S; Silver J; Kane RS; Stern JH; Temple S
Biomaterials; 2012 Apr; 33(10):2892-901. PubMed ID: 22243800
[TBL] [Abstract][Full Text] [Related]
36. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages.
Gensel JC; Donnelly DJ; Popovich PG
Expert Opin Ther Targets; 2011 Apr; 15(4):505-18. PubMed ID: 21281256
[TBL] [Abstract][Full Text] [Related]
37. Medusa's Head: The Complement System in Traumatic Brain and Spinal Cord Injury.
Roselli F; Karasu E; Volpe C; Huber-Lang M
J Neurotrauma; 2018 Jan; 35(2):226-240. PubMed ID: 28816089
[TBL] [Abstract][Full Text] [Related]
38. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Meli R; Bramanti P; Piomelli D; Calignano A; Cuzzocrea S
J Pharmacol Exp Ther; 2008 Jul; 326(1):12-23. PubMed ID: 18367664
[TBL] [Abstract][Full Text] [Related]
39. Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury.
Esposito E; Paterniti I; Mazzon E; Genovese T; Di Paola R; Galuppo M; Cuzzocrea S
Brain Behav Immun; 2011 Aug; 25(6):1099-112. PubMed ID: 21354467
[TBL] [Abstract][Full Text] [Related]
40. The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury.
Ceruti S; Villa G; Genovese T; Mazzon E; Longhi R; Rosa P; Bramanti P; Cuzzocrea S; Abbracchio MP
Brain; 2009 Aug; 132(Pt 8):2206-18. PubMed ID: 19528093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
